References
Lipsky B, Pecoraro R, Larson S, et al.: Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990, 150:790–797.
Joseph WS, Tan JS: Infections in diabetic foot ulcerations. Curr Infect Dis Rep 2003, 5:391–397.
Grayson M, Gibbons G, Habershaw G, et al.: Use of ampicillin/ sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994, 18:683–693.
NNIS System: National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003, 31:481–498.
Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 1999, 48:707–710.
Naimi TS, LeDell KH, Como-Sabetti K, et al.: Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976–2984.
Van Bambeke F, Van Laethem Y, Courvalin P, Tulkens PM:Glycopeptide antibiotics: from conventional molecules to new derivatives. Drugs 2004, 64:913–936.
Zhanel GG, Homenuik K, Nichol K, et al.: The glycylcyclines. A comparative review with the tetracyclines. Drugs 2004, 64:63–88.
Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996. MMWR Morb Mortal Wkly Rep 1997, 46:624–626.
Hiramatsu K, Hanaki H, Ino T, et al.: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997, 40:135–136.
Fridkin SK, Hageman JC, McDougal LK, et al.: Epidemiology and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001. Clin Infect Dis 2003, 36:429–439.
Liu C, Chambers HF: Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003, 47:3040–3045.
Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:565–567.
Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:565–567.
Chang S, Sievert DM, Hageman JC, et al.: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003, 348:1342–1347.
Centers for Disease Control and Prevention: Vancomycinresistant Staphylococcus aureus--New York, 2004. MMWR Morb Mortal Wkly Rep 2004, 53:322–323.
Rights and permissions
About this article
Cite this article
Tan, J.S. Foot Infections in diabetic patients. Curr Infect Dis Rep 6, 377–379 (2004). https://doi.org/10.1007/s11908-004-0036-z
Issue Date:
DOI: https://doi.org/10.1007/s11908-004-0036-z